#imToken# #4870# 我们正在完善 SEL 在 imToken 中的代币相关资料。完成后,大家可以在 imToken 里看到 logo,更方便地管理 SEL,同时能看到更多代币信息
Product architecture

It provides services for users, medical institutions, scientificresearch institutions and third parties around the industry through the five functional modules of Oread, Otrade, Oeducation, Oresearch and Oinsure.

Oread -a vertical community of stem cell information driven by token incentives

In the Oread module, whether the user is a consumer or a creator of the content, they would receive the token incentives from STEMC Eco Platform. Whenever users spend time on the STEMC platform would always be rewarded.

Otrade - the "Amazon" of stem cell industry

Otrade is a blockchain-based e-commerce platform perpendicular to the stem cell field.Both the upstream stem cell storage merchants or the downstream stem cell medical institutions can settle in the Otrade platform after pledging a certain number of tokens.

Oeducation - a vertical one-stop training and employment platform for the industry

Oeducation consists of three modules, namely training, conferences/forums and employment recruitment. The aim is to continuously bring high quality fresh blood to the industry through training and conferences/forums.

Oresearch - a research platform based on securities exchange of data and research results authorization

Oresearch is a platform for stem cell research and data sharing. On Oresearch, all data and research results that are conducive to the positive advancement of industry research will be valued. Through the platform, data & research results of research institutions and individuals or among research institutions can be shared at a price.

Oinsure - a matching therapeutic platform on stem cell chain

STEMC platform hopes to use Oinsure platform to break through the limitation of data sharing between countries and regions, collect more stem cell data and expand the sample pool of stem cell matching, so as to improve the probability of patients finding suitable stem cells for effective therapy.

Product architecture

It provides services for users, medical institutions, scientificresearch institutions and third parties around the industry through the five functional modules of Oread, Otrade, Oeducation, Oresearch and Oinsure.

Oread a vertical community of stem cell information driven by token incentives

In the Oread module, whether the user is a consumer or a creator of the content, they would receive the token incentives from STEMC Eco Platform. Whenever users spend time on the STEMC platform would always be rewarded.

Otrade the "Amazon" of stem cell industry

Otrade is a blockchain-based e-commerce platform perpendicular to the stem cell field.Both the upstream stem cell storage merchants or the downstream stem cell medical institutions can settle in the Otrade platform after pledging a certain number of tokens.

Oeducation a vertical one-stop training and employment platform for the industry

Oeducation consists of three modules, namely training, conferences/forums and employment recruitment. The aim is to continuously bring high quality fresh blood to the industry through training and conferences/forums.

Oresearch a research platform based on securities exchange of data and research results authorization

Oresearch is a platform for stem cell research and data sharing. On Oresearch, all data and research results that are conducive to the positive advancement of industry research will be valued. Through the platform, data & research results of research institutions and individuals or among research institutions can be shared at a price.

Oinsure a matching therapeutic platform on stem cell chain

STEMC platform hopes to use Oinsure platform to break through the limitation of data sharing between countries and regions, collect more stem cell data and expand the sample pool of stem cell matching, so as to improve the probability of patients finding suitable stem cells for effective therapy.

ROUTE
2019.12 Oread product online
2020.06 Otrade product online
2020.09 Oeducation Training function online
2020.11 Oeducation Conference function online
2021.06 Oeducation Recruitment function online
2021.12 Oresearch function online
2022.12 Oinsure online
EONOMIC MODEL

In order to rapidly promote the development of STEMC stem cell platform and realize its commercial application value, STEMC project issued 10 billion pieces of SEL based on ERC-20 token standard. The allocation rules are as follows

Type Quantity / 100 million Price(USDT/each subscription) Release rules Notes

Cornerstone distribution

2

0.0015

Lock up 100% of the positions, 25%should be released 3 months after SEL online and 5% each month later

Private distribution

6

0.0044

50% is released before the online exchange, and the rest is released after the online exchange in three months

Team reservation

10

/

years after SEL online exchanges, release 25% each year

For team motivation

Foundation reserves

10

/

Gradually released after SEL online exchange .

For marketing, product development and ecological construction

Ecological mining

70

/

Release rules as shown on the right

For ecological construction

Market business

2

/

Do not lock the position

For marketing and Pass-up on-line exchange

Type Quantity / 100 million Release rules The start time of release

Read mining

5

Creation mining

5

Exchange mining

20

Rating mining

5

Training mining

10

Authorization mining

5

Uploading mining

10

Others

10

LRelease 20% of the remaining amount each year; release the same number of SEL per day during the same year

Release 10% of the remaining amount each year; release the same number of SEL per day during the same year

/

2019.12

2019.12

2020.06

2020.06

2020.09

2021.12

2022.12

2019.12

TEAM
Frank Y.C. Liu/CEO Graduated from University of California, Berkeley

YAHOO BD.

QUANTA PM.

Taiwan network corporation APE's Co-Founder and CEO(Successfully completed M&A with Asia Pacific Telecom)

China's largest circulation company Guangzhou New Wide Union CEO(Create an average monthly income of 90 million to more than 400 million RMB within three years)

Kevin Zhang/COO Graduated from National University of Singapore

Former US stem cell research & application giant enterprise RegeneStem, Asia Pacific senior market operations officer;

One of the developers of standards for the lOT's integration with fully-automatic stem cell culture robot;

Years of strategy management and market experience in stem cell enterprises, strategic consulting and management consultant for many large stem cell enterprises.

Tristan Chen/CMO Graduated from Tokyo Institute of Technology

Former Unilever senior channel manager, one of the early evangelists of Bitcoin.

Unique insights and experience in project operation of different industrial chains in the blockchain industry.

Jason Bush/CTO Graduated from University of California, Berkeley

Former IBM and Google senior engineer with extensive experience in data distributed storage and distributed system design & development. Proficient in the common blockchain system architecture and implementation principle, in-depth research on blockchain expansion schemes as sharding, state channel and two-layer network.

Daniel Luo/CFO Graduated from Cornell University

Chinese certified public accountant(CPA)/  Chinese lawyer

American chartered financial analyst(CFA)/Prospective sponsor representative

Work experience in PricewaterhouseCoopers, Shenwan Hongyuan Securities investment bank. Skilled in finance, auditing, IPO, strategic management and other aspects.

Cornelius/CPO Graduated from Nanyang Technological University

Former senior product manager of Sea Ltd, a leading Internet company in Singapore;

With product design experience of millions of users, in-depth research and unique insights into the underlying architecture design of blockchain products and the design of business models in the biomedical field.

CONSULTANTS
Imai Masako

Ph.D. in Pharmacy, University of Michigan, project leader and chairman of MIH group; assistant professor at Illinois State University Medical Center Hospital in Chicago. Rich experience in pharmacokinetics and clinical trial research and development; engaged in the department of clinical pharmacology, National Medical Research Center, Ministry of Health and Social Security. He was sent to the university of California, San Francisco to receive overseas research from the Japanese government and to conduct research on pharmacokinetics.

Liu Ming

Ph.D., Institute of Cell Molecular and Developmental Biology, University of California, Riverside; Professor, China University of Culture. In-depth studies in the fields of molecular cell biology, reproductive science, and stem cell science.

Zhang Shangquan

He is the founder of DCCIK for cellular immunity in China, and a professor at the institute of biochemistry and cell sciences, Chinese academy of sciences. He is engaged in major research projects of Shanghai institute of biochemistry and cell biology, Chinese academy of sciences. He is the first responsible person of clinical application of DCCIK cell preparation.The preparation of DCCIK cells received the clinical study batch number of China food and drug administration: 2005LD1561. Clinical application of tens of thousands of cases, to save cancer and other patients, make outstanding contributions to health.

PARTNER